Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInvested CapitalMarket CapitalizationReturn on AssetsReturn on Capital EmployedReturn on Equity

Contineum Therapeutics (CTNM) Return on Assets: 2024

Historic Return on Assets for Contineum Therapeutics (CTNM) over the last 1 years, with Dec 2024 value amounting to -0.20%.

  • Contineum Therapeutics' Return on Assets was N/A to -0.20% in Q4 2024 from the same period last year, while for Dec 2024 it was -0.20%, marking a year-over-year change of. This contributed to the annual value of -0.25% for FY2024, which is N/A change from last year.
  • According to the latest figures from Q4 2024, Contineum Therapeutics' Return on Assets is -0.20%, which was down 21.53% from -0.16% recorded in Q3 2024.
  • Contineum Therapeutics' Return on Assets' 5-year high stood at 0.15% during Q1 2024, with a 5-year trough of -0.20% in Q4 2024.
  • For the 1-year period, Contineum Therapeutics' Return on Assets averaged around -0.10%, with its median value being -0.17% (2024).